Archives

Pegrizeprument Granted Orphan Drug Designation for Prevention of Organ Rejection in Heart Transplant Patients

B CARY, N.C., April 22, 2026 /PRNewswire/ — Veloxis Pharmaceuticals, Inc. (Veloxis), a global specialty pharmaceutical company part of Asahi Kasei Corporation, announced today that pegrizeprument… Login to continue reading Login…

Read MorePegrizeprument Granted Orphan Drug Designation for Prevention of Organ Rejection in Heart Transplant Patients

Skiptown Reports 40%+ YoY Revenue Growth, Surpasses 8,000 Memberships, and up 68% YoY in Q1 Daycare Bundle Sales

B Pet Care Brand Continues Rapid Expansion with First Multi-Unit Franchise Agreement CHARLOTTE, N.C., April 22, 2026 /PRNewswire/ — Skiptown, the modern, tech-enabled dog care franchise,… Login to continue reading Login…

Read MoreSkiptown Reports 40%+ YoY Revenue Growth, Surpasses 8,000 Memberships, and up 68% YoY in Q1 Daycare Bundle Sales